Simplify Health Care ETF (PINK) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PINK 5.1 out of 10 — highest on Growth (8.3), lowest on Quality (1.4). It trades at 32.3 times earnings, against its own median of 29.0. Its ten largest holdings are 56% of the fund.
What stands out in PINK's data
U.S. health care innovators, from biotech to medical devices.
Its profit margins trail those of similar funds — the portfolio's edge has to come from growth, not efficiency.
EBITDA margin of 20.3% sits behind the category median of 20.5% and below its own historical median of 21.1%. Top 10 holdings make up 56% of assets.
A satellite sleeve for a health care allocation, built around high-growth medical names.
Why did PINK move this week? It rose 1.0% in the week to October 9, 2026 — Humana and Pacira Biosciences drove it
PINK rose 1.0% in the week to October 9, 2026. The holdings that moved it most were Humana (+11.2%), Pacira Biosciences (+44.0%) and Arcutis Biotherapeutics (+5.6%); Purecycle Technologies (−10.7%) pushed the other way.
How is PINK rated? ETF Copilot scores Simplify Health Care ETF (PINK) 5.1 out of 10
As of October 9, 2026, ETF Copilot scores Simplify Health Care ETF (PINK) 5.1 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 5.1 / 10
- Growth: 8.3 / 10
- Value: 2.5 / 10
- Risk: 7.0 / 10
- Quality: 1.4 / 10
- Return: 4.8 / 10
Is PINK expensive right now? It trades at 32.3 times earnings, against its own median of 29.0
As of October 9, 2026, PINK is more expensive than 77% of its own last 5 years.
Trailing 12 months, built from PINK's holdings. How we calculate this →
What's inside PINK?
What's inside PINK: Size (Large 48%, Mid 29%, Small 22%); Geography (International 5%, US 95%); AI 0.8%.
What are PINK's top holdings? The ten largest are 56% of the fund
Eli Lilly, Humana, United Therapeutics, Arcutis Biotherapeutics, Abbvie, Thermo Fisher Scientific, Warby Parker, Johnson + Johnson, UnitedHealth and Avantor are PINK's largest holdings, in that order.
More concentrated than 72% of Health & Biotech ETFs.
Half of PINK's weight sits in its 9 largest positions, and once those weights are taken into account it behaves like 23 equally weighted holdings.
What is PINK's expense ratio? 0.51% a year
As of October 9, 2026, PINK charges 0.51% a year, yields 0.77% and holds $310M in assets across 52 positions.
| Measure | PINK |
|---|---|
| Expense ratio | 0.51% |
| Dividend yield | 0.77% |
| Assets under management | $310M |
| Holdings | 52 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Simplify Health Care ETF (PINK) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/pink
ETF Copilot Pro unlocks PINK's price and what each holding weighs.
Try Pro free →